Stop the Asthma Treatment Elevator, We Need to Get Off!
作者信息
Bush Andy, Pavord Ian D
机构信息
Imperial College London, London, United Kingdom of Great Britain and Northern Ireland;
Oxford University, Nuffield department of Medicine, Respiratory Medicine, Oxford, Oxfordshire, United Kingdom of Great Britain and Northern Ireland.
出版信息
Am J Respir Crit Care Med. 2025 Jan 21;211(5):698-9. doi: 10.1164/rccm.202412-2431VP.
Abstract
摘要
相似文献
1
Stop the Asthma Treatment Elevator, We Need to Get Off!停下哮喘治疗的电梯，我们要下去！
Am J Respir Crit Care Med. 2025 Jan 21;211(5):698-9. doi: 10.1164/rccm.202412-2431VP.
2
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.哮喘中的气道炎症、基底膜增厚和支气管高反应性。
Thorax. 2002 Apr;57(4):309-16. doi: 10.1136/thorax.57.4.309.
3
Compartmental and temporal dynamics of chronic inflammation and airway remodelling in a chronic asthma mouse model.慢性哮喘小鼠模型中慢性炎症和气道重塑的区室化及时间动态变化
PLoS One. 2014 Jan 21;9(1):e85839. doi: 10.1371/journal.pone.0085839. eCollection 2014.
4
Cysteinyl leukotriene D (LTD) promotes airway epithelial cell inflammation and remodelling.半胱氨酰白三烯 D（LTD）可促进气道上皮细胞炎症和重塑。
Inflamm Res. 2021 Jan;70(1):109-126. doi: 10.1007/s00011-020-01416-z. Epub 2020 Nov 2.
5
MicroRNA-21 inhibition attenuates airway inflammation and remodelling by modulating the transforming growth factor β-Smad7 pathway.miRNA-21 抑制通过调节转化生长因子-β-Smad7 通路减轻气道炎症和重塑。
Korean J Intern Med. 2021 May;36(3):706-720. doi: 10.3904/kjim.2020.132. Epub 2021 Feb 18.
6
Effect of roflumilast on airway remodelling in a murine model of chronic asthma.罗氟司特对慢性哮喘小鼠模型气道重塑的影响。
Clin Exp Allergy. 2016 May;46(5):754-63. doi: 10.1111/cea.12670.
7
Novel concepts in airway inflammation and remodelling in asthma.哮喘气道炎症和重塑的新概念。
Eur Respir J. 2015 Dec;46(6):1796-804. doi: 10.1183/13993003.01196-2014. Epub 2015 Nov 5.
8
Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model.白细胞介素-18缺陷小鼠在卵清蛋白诱导的哮喘模型中表现出慢性炎症减轻和气道重塑减少。
Clin Exp Immunol. 2008 Dec;154(3):295-304. doi: 10.1111/j.1365-2249.2008.03772.x. Epub 2008 Sep 23.
9
Lignosus rhinocerotis extract ameliorates airway inflammation and remodelling via attenuation of TGF-β1 and Activin A in a prolonged induced allergic asthma model.隆射多孔菌提取物通过抑制转化生长因子-β1 和激活素 A 减轻延长诱导的变应性哮喘模型中的气道炎症和重塑。
Sci Rep. 2023 Oct 27;13(1):18442. doi: 10.1038/s41598-023-45640-z.
10
Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis.哮喘患者气道炎症、网状基底膜增厚与对乙酰甲胆碱支气管高反应性之间的相互关系；一项系统性支气管肺泡灌洗和气道活检分析
Clin Exp Allergy. 2005 Dec;35(12):1565-71. doi: 10.1111/j.1365-2222.2005.02365.x.
引用本文的文献
1
Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review.以生物制剂试验为重点的已确立和新兴哮喘生物标志物：叙述性综述
J Pers Med. 2025 Aug 13;15(8):370. doi: 10.3390/jpm15080370.
2
Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion.开启哮喘缓解之路：专家圆桌讨论的关键见解
Respirology. 2025 Jun;30(6):466-479. doi: 10.1111/resp.70047. Epub 2025 May 23.
本文引用的文献
1
Blood Eosinophil Count: Lack of Stability and Association with Wheeze Attacks in Preschool Children.血液嗜酸性粒细胞计数：学龄前儿童缺乏稳定性且与喘息发作无关
Am J Respir Crit Care Med. 2025 Feb;211(2):263-265. doi: 10.1164/rccm.202406-1121RL.
2
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.探索成人接受生物治疗后重度哮喘临床缓解的定义和预测因素。
Am J Respir Crit Care Med. 2024 Oct 1;210(7):869-880. doi: 10.1164/rccm.202311-2192OC.
3
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.哮喘患者中与肺功能下降及度普利尤单抗反应相关的生物标志物
Am J Respir Crit Care Med. 2024 Apr 15;209(8):1031-1033. doi: 10.1164/rccm.202310-1751LE.
4
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma.血液嗜酸性粒细胞和呼出气一氧化氮分数是儿童哮喘的预后和预测生物标志物。
J Allergy Clin Immunol. 2024 Jul;154(1):101-110. doi: 10.1016/j.jaci.2023.09.044. Epub 2024 Jan 23.
5
Type-2 inflammation and lung function decline in chronic airway disease in the general population.2 型炎症与普通人群慢性气道疾病肺功能下降
Thorax. 2024 Mar 15;79(4):349-358. doi: 10.1136/thorax-2023-220972.
6
Clinically accessible biomarkers to assess the modifiable risk of asthma/wheezing attacks in toddlers.用于评估幼儿哮喘/喘息发作可改变风险的临床可获取生物标志物。
J Allergy Clin Immunol Pract. 2023 Jun;11(6):1984-1985. doi: 10.1016/j.jaip.2023.02.042.
7
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide.基于血液嗜酸性粒细胞和呼出气一氧化氮的哮喘发作风险原型量表的推导。
Thorax. 2022 Feb;77(2):199-202. doi: 10.1136/thoraxjnl-2021-217325. Epub 2021 Aug 6.
8
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.复合 2 型生物标志物策略与基于症状风险的算法调整重度哮喘患者皮质类固醇剂量：一项多中心、单盲、平行组、随机对照试验。
Lancet Respir Med. 2021 Jan;9(1):57-68. doi: 10.1016/S2213-2600(20)30397-0. Epub 2020 Sep 8.
9
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.血嗜酸性粒细胞和呼出气一氧化氮对轻度哮喘成人的预测价值：一项开放标签、平行组、随机对照试验的预先指定亚组分析。
Lancet Respir Med. 2020 Jul;8(7):671-680. doi: 10.1016/S2213-2600(20)30053-9. Epub 2020 Mar 11.
10
Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.按需使用布地奈德-福莫特罗治疗轻度哮喘的对照试验。
N Engl J Med. 2019 May 23;380(21):2020-2030. doi: 10.1056/NEJMoa1901963. Epub 2019 May 19.
Zotero 插件